Jennifer S. Gewandter is an Associate Professor at the University of Rochester School of Medicine and Dentistry , with joint appointments in the Departments of Anesthesiology and Perioperative Medicine, Dentistry, Neurology, and Neurosurgery . Her research focuses on chronic pain, chemotherapy-induced peripheral neuropathy (CIPN), patient-reported outcomes, and clinical trial methodologies. Education: PhD in Biochemistry (2011) and MPH in Public Health (2014) from the University of Rochester; MS in Biochemistry (2008); BS in Biochemistry (2004) from SUNY Geneseo. Dr. Gewandter leads studies on CIPN treatment, pain biomarkers, and neuromodulation techniques, publishing extensively in journals like Pain and The Journal of Pain . Her work emphasizes improving clinical trial design, assay sensitivity, and patient-centered pain management. She has received awards such as the Early Career Women Faculty Leadership Development Workshop (2018) , Distributed Research Network Demonstration Project Award (2017) , and Marvel-dare F. Nutting Award (2012) , alongside predoctoral grants and fellowships. Her recent articles analyze buprenorphine initiation predictors, social disparities in pain treatment, and innovative approaches to CIPN prevention via exercise and neuromodulation. She advocates for rigorous statistical methods and patient engagement in clinical research.












